Currently, Ampio Pharmaceuticals Inc.’s (AMPE) stock is trading at $0.30, marking a gain of 27.27% from last night’s close. At this price, the stock is -87.51% below its 52-week high of $2.37 and 64.39% above its 52-week low of $0.18.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, AMPE’s SMA-200 is $0.2913.
AMPE’s price to book ratio for the most recent quarter was 0.57, resulting in an 0.42 price to cash per share for the period.
How does Ampio Pharmaceuticals Inc. (AMPE) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a No Ratings. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Ampio Pharmaceuticals Inc. (AMPE): Earnings History
If we examine Ampio Pharmaceuticals Inc.’s recent earnings history, in the last quarter ended on 6/29/2022, it posted adjusted earnings per share of -$0.01, slashing the consensus of -$0.02. In other words, it beat the consensus by $0.01, resulting in a 50.00% surprise. In the 3 months period before the previous quarter which was closed on 6/29/2022, the stock recorded adjusted earnings per share of -$0.01 in contrast with the Outlook of -$0.02. That was a difference of $0.01 and a surprise of 50.00%.
Ampio Pharmaceuticals Inc. (AMEX: AMPE) Ownership Details
I will give a breakdown of the key shareholders in Ampio Pharmaceuticals Inc. (AMPE). Recent figures show that the company’s insiders hold 8.71% of shares. A total of 42 institutional investors hold shares in the company, making 3.73% of its stock and 4.09% of its float.
Mar 30, 2023, it was reported that the Company’s largest institutional holder is HRT Financial LP holding total of 0.22 million shares that make 1.44% of the company’s total number of shares and are currently priced at 67242.0.
The securities firm CVA Family Office, LLC holds 73567.0 shares of AMPE, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.49%, and the holding percentage of shares is valued at 22791.0.
An overview of Ampio Pharmaceuticals Inc.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Ampio Pharmaceuticals Inc. (AMPE) traded 584,650 shares per day, with a moving average of $0.2495 and price change of +0.1797. With the moving average of $0.2600 and a price change of +0.1406, about 314,054 shares changed hands on average over the past 50 days. Finally, AMPE’s 100-day average volume is 374,448 shares, alongside a moving average of $0.2483 and a price change of +0.1149.
